Viewing nowCombinationEGLIPTINE IR Tablets 50/850 mg
Sitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.

MFDS item code 202204603 · Approved 2022.12.21 · Insurance code 658204670
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to assist in blood glucose control in patients with type 2 diabetes who are taking sitagliptin and metformin together. When taken alongside controlled diet and exercise therapy, effective management of blood glucose can be achieved. By improving blood glucose levels, it also contributes to the prevention of complications, thus aiding in consistent treatment.
In antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. This medicine is generally taken twice daily with meals. To reduce gastrointestinal adverse reactions caused by metformin, the dose should be increased gradually. The initial dose of this medicine should be determined according to the patient's current treatment regimen. 1. Patients not currently receiving metformin treatment: For patients with no previous experience of antidiabetic drug therapy for whom adequate glycemic control is difficult to achieve with monotherapy, or for whom adequate glycemic control cannot be achieved with sitagliptin monotherapy, the initial dose of this medicine is 1 tablet of 50/500 mg twice daily. The dose may be increased to 1 tablet of 50/1000 mg twice daily. Patients with renal impairment who are receiving a reduced dose of sitagliptin should not be switched to this medicine. 2. Patients receiving metformin treatment: - The recommended initial dose of this medicine for patients who cannot achieve adequate glycemic control with metformin monotherapy is sitagliptin 50 mg twice daily (total daily dose 100 mg) and the patient's existing metformin dose. - Patients switching from combination therapy with sitagliptin and metformin to this medicine may start at their existing doses of sitagliptin and metformin. 3. Patients who cannot achieve adequate glycemic control with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial dose of this medicine is sitagliptin 50 mg twice daily (total daily dose 100 mg), and the initial dose of metformin should be determined taking the patient's blood glucose level and existing dose into consideration. To reduce gastrointestinal adverse reactions caused by metformin, the dose should be increased gradually. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. Patients with renal impairment This medicine may be used in patients with moderate renal impairment stage 3a (creatinine clearance [CrCl] ≥ 45 and < 60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and < 60 mL/min/1.73m2) who have no other conditions that may increase the risk of lactic acidosis, provided that the following dose adjustments are made. Since the starting dose of metformin is 500 mg or 850 mg once daily, treatment should not be initiated with this medicine. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 mL/min or eGFR < 45 mL/min/1.73m2, this medicine should be discontinued immediately.
This medication consists of sitagliptin and metformin and is used for diabetes treatment. While taking this medication, serious allergic reactions may occur, so if symptoms such as rash, difficulty breathing, or swelling of the face or neck appear, discontinue use immediately and inform your doctor. There have been reports of severe adverse effects, such as pancreatitis (inflammation of the pancreas), so if symptoms such as abdominal pain, nausea, vomiting, or loss of appetite occur, seek medical attention promptly. Patients with severely impaired kidney function or in situations where acute kidney failure is at risk should not take this medication, and it must be discontinued especially before and after examinations using iodinated contrast agents. Women who are pregnant or may become pregnant, and nursing mothers should not use this medication. This medication can induce hypoglycemia, so caution is needed if meals are skipped or irregular, during intense exercise, or when taken with other antidiabetic medications. During treatment, regular checks of kidney function and blood tests should be conducted, and since vitamin B12 levels may decrease, supplementation may be required if necessary. Alcohol consumption may increase the risk of side effects associated with this medication, therefore, it is advisable to avoid drinking alcohol during treatment. Prior to and after surgery, this medication should be discontinued for a certain period and should only be resumed after kidney function has returned to normal. If sudden joint pain, skin rash, or blisters occur while taking this medication, consult a doctor immediately. This medication may interact with other drugs, so it is crucial to inform healthcare professionals of any other medications being taken, especially when co-administered with drugs that may affect kidney function. Elderly patients should be cautious due to the common decline in kidney function; dose adjustment and regular kidney function monitoring are necessary. In case of overdose, promptly visit a medical institution for appropriate treatment, and this medication can be partially removed through hemodialysis.
anaphylaxis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. By doing so, the effectiveness of the medication can be maintained for a longer period.
Oval-shaped film-coated tablets in dark pink color
56 tablets - 56 tablets/box [(14 tablets/PTP x 4)], 30 tablets - 30 tablets/bottle, 200 tablets - 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.